Regeneron Proves Insurmountable As Second FDA Approved Eylea Biosimilar Blocked

Samsung Bioepis Joins Biocon In Feeling Weight Of Injunction; Amgen On Separate Track

 
• By Dean Rudge
  
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin